Redmile Group, LLC Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Redmile Group, LLC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Redmile Group, LLC. Redmile Group, LLC is 10% Owner in ARRAY BIOPHARMA INC ($ARRY) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in VAPOTHERM INC ($VAPO) and in XERIS PHARMACEUTICALS INC ($XERS) and 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and 10% Owner in Neoleukin Therapeutics, Inc. ($NLTX) and in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Director in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Director in FATE THERAPEUTICS INC ($FATE) and Director in IGM Biosciences, Inc. ($IGMS) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Atreca, Inc. ($BCEL) and 10% Owner in Nurix Therapeutics, Inc. ($NRIX) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Allakos Inc. ($ALLK) and 10% Owner in Stoke Therapeutics, Inc. ($STOK) and Director in Shattuck Labs, Inc. ($STTK) and 10% Owner in Replimune Group, Inc. ($REPL) and 10% Owner in PLIANT THERAPEUTICS, INC. ($PLRX) and 10% Owner in Beam Therapeutics Inc. ($BEAM) and 10% Owner in Gritstone Oncology, Inc. ($GRTS) and 10% Owner in Allovir, Inc. ($ALVR) and 10% Owner in Cabaletta Bio, Inc. ($CABA) and 10% Owner in Akero Therapeutics, Inc. ($AKRO) and 10% Owner in TCR2 THERAPEUTICS INC. ($TCRR) and 10% Owner in HOOKIPA Pharma Inc. ($HOOK) and 10% Owner in Aprea Therapeutics, Inc. ($APRE) and 10% Owner in Repare Therapeutics Inc. ($RPTX) and 10% Owner in Kymera Therapeutics, Inc. ($KYMR).

Latest Insider Trading Transactions of Redmile Group, LLC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AKRO, ALDR, ALLK, ALVR, FOLD, ANNX, APRE, ARRY, BCEL, BEAM, CABA, FATE, GRTS, HOOK, IGMS, KYMR, NLTX, NRIX, PLRX, RPTX, REPL, STTK, STOK, SYRS, TCRR, VAPO, XERS

Page: 1 2 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 22 2021	STTK	Shattuck Labs, Inc ...	Redmile Group, LLC	Director	Option Exercise	A	29.34	3,434	100,754	3,434
Apr 02 2021	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Grant	A	0.00	130	0	3,426,297	3.4 M to 3.4 M (0.00 %)
Feb 16 2021	APRE	Aprea Therapeutics ...	Redmile Group, LLC	10% Owner	Sell	S	5.80	5,863	34,005	1,768,718	1.8 M to 1.8 M (-0.33 %)
Feb 16 2021	APRE	Aprea Therapeutics ...	Redmile Group, LLC	10% Owner	Sell	S	5.58	494,137	2,757,284	1,774,581	2.3 M to 1.8 M (-21.78 %)
Jan 12 2021	FATE	FATE THERAPEUTICS ...	Redmile Group, LLC	Director	Option Exercise	P	0.00	257,310	257	257,310
Jan 12 2021	FATE	FATE THERAPEUTICS ...	Redmile Group, LLC	Director	Buy	P	85.50	327,485	27,999,968	12,957,222	12.6 M to 13 M (+2.59 %)
Jan 05 2021	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Grant	A	0.00	178	0	3,426,167	3.4 M to 3.4 M (+0.01 %)
Dec 28 2020	STTK	Shattuck Labs, Inc ...	Redmile Group, LLC	Director	Option Exercise	A	53.02	1,286	68,184	1,286
Dec 15 2020	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Option Exercise	P	0.01	667,666	6,677	667,666
Oct 15 2020	STTK	Shattuck Labs, Inc ...	Redmile Group, LLC	Director	Option Exercise	C	0.00	318,064	0	0
Oct 15 2020	STTK	Shattuck Labs, Inc ...	Redmile Group, LLC	Director	Buy	P	22.10	50,000	1,105,000	5,619,914	5.6 M to 5.6 M (+0.90 %)
Oct 15 2020	STTK	Shattuck Labs, Inc ...	Redmile Group, LLC	Director	Buy	P	21.09	31,695	668,308	5,569,914	5.5 M to 5.6 M (+0.57 %)
Oct 15 2020	STTK	Shattuck Labs, Inc ...	Redmile Group, LLC	Director	Buy	P	20.00	65,047	1,300,797	5,538,219	5.5 M to 5.5 M (+1.19 %)
Oct 15 2020	STTK	Shattuck Labs, Inc ...	Redmile Group, LLC	Director	Buy	P	19.20	195,158	3,747,580	5,473,172	5.3 M to 5.5 M (+3.70 %)
Oct 15 2020	STTK	Shattuck Labs, Inc ...	Redmile Group, LLC	Director	Buy	P	18.01	158,100	2,847,666	5,278,014	5.1 M to 5.3 M (+3.09 %)
Oct 15 2020	STTK	Shattuck Labs, Inc ...	Redmile Group, LLC	Director	Buy	P	17.00	2,941,176	49,999,992	5,119,914	2.2 M to 5.1 M (+134.99 %)
Oct 15 2020	STTK	Shattuck Labs, Inc ...	Redmile Group, LLC	Director	Buy	C	0.00	2,178,738	0	2,178,738	0 to 2.2 M
Sep 09 2020	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Buy	P	51.85	8,650	448,523	3,425,811	3.4 M to 3.4 M (+0.25 %)
Sep 09 2020	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Buy	P	52.96	14,610	773,811	3,417,161	3.4 M to 3.4 M (+0.43 %)
Sep 09 2020	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Buy	P	49.91	47,113	2,351,504	3,402,551	3.4 M to 3.4 M (+1.40 %)
Sep 09 2020	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Buy	P	50.28	74,433	3,742,186	3,355,438	3.3 M to 3.4 M (+2.27 %)
Sep 03 2020	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Buy	P	48.69	74,253	3,615,208	3,281,005	3.2 M to 3.3 M (+2.32 %)
Sep 03 2020	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Buy	P	46.76	19,173	896,593	3,206,752	3.2 M to 3.2 M (+0.60 %)
Sep 03 2020	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Buy	P	45.54	1,464	66,674	3,187,579	3.2 M to 3.2 M (+0.05 %)
Sep 03 2020	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Buy	P	44.84	41,759	1,872,327	3,186,115	3.1 M to 3.2 M (+1.33 %)
Aug 25 2020	KYMR	Kymera Therapeutic ...	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	2,600,740	0	0
Aug 25 2020	KYMR	Kymera Therapeutic ...	Redmile Group, LLC	10% Owner	Buy	C	0.00	1,630,660	0	1,630,660	0 to 1.6 M
Aug 05 2020	ALVR	Allovir, Inc.	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	1,226,993	0	0
Aug 05 2020	ALVR	Allovir, Inc.	Redmile Group, LLC	10% Owner	Buy	C	0.00	823,371	0	823,371	0 to 823.4 K
Jul 30 2020	ANNX	Annexon, Inc.	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	14,062,719	0	0
Jul 30 2020	ANNX	Annexon, Inc.	Redmile Group, LLC	10% Owner	Buy	C	0.00	1,596,222	0	1,596,222	0 to 1.6 M
Jul 30 2020	NRIX	Nurix Therapeutics ...	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	1,176,470	0	0
Jul 30 2020	NRIX	Nurix Therapeutics ...	Redmile Group, LLC	10% Owner	Buy	C	0.00	1,176,470	0	1,176,470	0 to 1.2 M
Jul 06 2020	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Grant	A	0.00	178	0	3,144,356	3.1 M to 3.1 M (+0.01 %)
Jun 25 2020	RPTX	Repare Therapeutic ...	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	1,586,174	0	0
Jun 25 2020	RPTX	Repare Therapeutic ...	Redmile Group, LLC	10% Owner	Buy	C	0.00	1,586,174	0	1,586,174	0 to 1.6 M
Jun 17 2020	FATE	FATE THERAPEUTICS ...	Redmile Group, LLC	Director	Buy	P	28.31	1,412,928	39,999,992	12,629,737	11.2 M to 12.6 M (+12.60 %)
Jun 09 2020	PLRX	PLIANT THERAPEUTIC ...	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	13,661,202	0	0
Jun 09 2020	PLRX	PLIANT THERAPEUTIC ...	Redmile Group, LLC	10% Owner	Buy	C	0.00	1,910,657	0	1,910,657	0 to 1.9 M
May 05 2020	FATE	FATE THERAPEUTICS ...	Redmile Group, LLC	Director	Option Exercise	A	26.59	16,000	425,440	16,000
Apr 06 2020	NLTX	Neoleukin Therapeu ...	Redmile Group, LLC	10% Owner	Sell	S	11.82	100	1,182	4,041,211	4 M to 4 M (0.00 %)
Apr 06 2020	NLTX	Neoleukin Therapeu ...	Redmile Group, LLC	10% Owner	Sell	S	11.30	9,734	110,032	4,041,311	4.1 M to 4 M (-0.24 %)
Apr 06 2020	NLTX	Neoleukin Therapeu ...	Redmile Group, LLC	10% Owner	Buy	P	11.85	1,000	11,851	4,051,045	4.1 M to 4.1 M (+0.02 %)
Apr 06 2020	NLTX	Neoleukin Therapeu ...	Redmile Group, LLC	10% Owner	Buy	P	11.36	38,300	435,107	4,050,045	4 M to 4.1 M (+0.95 %)
Apr 06 2020	NLTX	Neoleukin Therapeu ...	Redmile Group, LLC	10% Owner	Sell	S	11.87	200	2,373	4,011,745	4 M to 4 M (0.00 %)
Apr 06 2020	NLTX	Neoleukin Therapeu ...	Redmile Group, LLC	10% Owner	Sell	S	11.06	9,634	106,567	4,011,945	4 M to 4 M (-0.24 %)
Apr 06 2020	NLTX	Neoleukin Therapeu ...	Redmile Group, LLC	10% Owner	Buy	P	11.65	9,000	104,865	4,021,579	4 M to 4 M (+0.22 %)
Apr 06 2020	NLTX	Neoleukin Therapeu ...	Redmile Group, LLC	10% Owner	Buy	P	10.95	33,500	366,765	4,012,579	4 M to 4 M (+0.84 %)
Apr 06 2020	NLTX	Neoleukin Therapeu ...	Redmile Group, LLC	10% Owner	Buy	P	10.71	7,500	80,309	3,979,079	4 M to 4 M (+0.19 %)
Apr 06 2020	NLTX	Neoleukin Therapeu ...	Redmile Group, LLC	10% Owner	Buy	P	10.18	22,500	229,079	3,971,579	3.9 M to 4 M (+0.57 %)
Apr 06 2020	NLTX	Neoleukin Therapeu ...	Redmile Group, LLC	10% Owner	Buy	P	10.27	2,700	27,741	3,949,079	3.9 M to 3.9 M (+0.07 %)
Apr 06 2020	NLTX	Neoleukin Therapeu ...	Redmile Group, LLC	10% Owner	Buy	P	9.91	29,800	295,169	3,946,379	3.9 M to 3.9 M (+0.76 %)
Apr 06 2020	NLTX	Neoleukin Therapeu ...	Redmile Group, LLC	10% Owner	Buy	P	9.21	50,000	460,395	3,916,579	3.9 M to 3.9 M (+1.29 %)
Apr 03 2020	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Option Exercise	A	40.27	10,000	402,700	10,000
Apr 03 2020	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Grant	A	0.00	178	0	3,144,178	3.1 M to 3.1 M (+0.01 %)
Feb 11 2020	BEAM	Beam Therapeutics ...	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	5,208,333	0	0
Feb 11 2020	BEAM	Beam Therapeutics ...	Redmile Group, LLC	10% Owner	Buy	C	0.00	1,161,458	0	1,161,458	0 to 1.2 M
Oct 29 2019	CABA	Cabaletta Bio, Inc ...	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	1,044,568	0	0
Oct 29 2019	CABA	Cabaletta Bio, Inc ...	Redmile Group, LLC	10% Owner	Buy	C	0.00	696,378	0	696,378	0 to 696.4 K
Oct 24 2019	ALDR	ALDER BIOPHARMACEU ...	Redmile Group, LLC	Director	Option Exercise	D	11.01	22,500	247,725	0
Oct 24 2019	ALDR	ALDER BIOPHARMACEU ...	Redmile Group, LLC	Director	Option Exercise	D	15.50	15,000	232,500	0
Oct 24 2019	ALDR	ALDER BIOPHARMACEU ...	Redmile Group, LLC	Director	Option Exercise	D	13.20	30,000	396,000	0
Oct 24 2019	ALDR	ALDER BIOPHARMACEU ...	Redmile Group, LLC	Director	Option Exercise	U	0.00	20,243	0	0
Oct 24 2019	ALDR	ALDER BIOPHARMACEU ...	Redmile Group, LLC	Director	Option Exercise	D	188.64	54,757	10,329,360	20,243
Oct 24 2019	ALDR	ALDER BIOPHARMACEU ...	Redmile Group, LLC	Director	Option Exercise	X	0.00	75,000	0	75,000
Oct 24 2019	ALDR	ALDER BIOPHARMACEU ...	Redmile Group, LLC	Director	Option Exercise	X	137.88	75,000	10,341,000	0
Oct 24 2019	ALDR	ALDER BIOPHARMACEU ...	Redmile Group, LLC	Director	Option Exercise	J	137.88	75,000	10,341,000	75,000
Oct 24 2019	ALDR	ALDER BIOPHARMACEU ...	Redmile Group, LLC	Director	Option Exercise	U	0.00	779,776	0	0
Oct 24 2019	ALDR	ALDER BIOPHARMACEU ...	Redmile Group, LLC	Director	Sell	U	0.00	8,244,896	0	0	8.2 M to 0 (-100.00 %)
Oct 08 2019	APRE	Aprea Therapeutics ...	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	1,164,674	0	0
Oct 08 2019	APRE	Aprea Therapeutics ...	Redmile Group, LLC	10% Owner	Buy	P	15.00	400,000	6,000,000	2,268,718	1.9 M to 2.3 M (+21.41 %)
Oct 08 2019	APRE	Aprea Therapeutics ...	Redmile Group, LLC	10% Owner	Buy	C	0.00	1,868,718	0	1,868,718	0 to 1.9 M
Sep 23 2019	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Option Exercise	C	0.00	1,891,530	0	1,891,530
Sep 23 2019	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Option Exercise	C	0.00	1,891,530	0	0
Sep 23 2019	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Grant	A	16.00	3,144,000	50,304,000	3,144,000	0 to 3.1 M
Sep 23 2019	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Option Exercise	C	0.00	1,891,530	0	1,891,530
Sep 23 2019	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Option Exercise	C	0.00	1,891,530	0	0
Sep 23 2019	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Grant	A	16.00	3,144,000	50,304,000	3,144,000	0 to 3.1 M
Sep 19 2019	IGMS	IGM Biosciences, I ...	Redmile Group, LLC	Director	Option Exercise	A	16.00	12,100	193,600	12,100
Sep 17 2019	FATE	FATE THERAPEUTICS ...	Redmile Group, LLC	Director	Buy	P	17.50	857,143	15,000,003	11,216,809	10.4 M to 11.2 M (+8.27 %)
Aug 02 2019	FATE	FATE THERAPEUTICS ...	Redmile Group, LLC	Director	Option Exercise	G	0.00	25,000	0	0
Aug 02 2019	FATE	FATE THERAPEUTICS ...	Redmile Group, LLC	Director	Option Exercise	J	0.00	25,000	0	25,000
Aug 02 2019	FATE	FATE THERAPEUTICS ...	Redmile Group, LLC	Director	Option Exercise	J	0.00	25,000	0	2,794,549
Jul 01 2019	ALDR	ALDER BIOPHARMACEU ...	Redmile Group, LLC	Director	Option Exercise	A	0.00	19,023	0	779,776
Jun 24 2019	BCEL	Atreca, Inc.	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	715,306	0	0
Jun 24 2019	BCEL	Atreca, Inc.	Redmile Group, LLC	10% Owner	Buy	C	0.00	715,306	0	715,306	0 to 715.3 K
Jun 24 2019	AKRO	Akero Therapeutics ...	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	2,286,585	0	0
Jun 24 2019	AKRO	Akero Therapeutics ...	Redmile Group, LLC	10% Owner	Buy	C	0.00	743,802	0	743,802	0 to 743.8 K
Jun 24 2019	STOK	Stoke Therapeutics ...	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	671,808	0	0
Jun 24 2019	STOK	Stoke Therapeutics ...	Redmile Group, LLC	10% Owner	Buy	C	0.00	671,808	0	671,808	0 to 671.8 K
May 24 2019	ALDR	ALDER BIOPHARMACEU ...	Redmile Group, LLC	Director	Option Exercise	A	11.01	22,500	247,725	22,500
May 06 2019	FATE	FATE THERAPEUTICS ...	Redmile Group, LLC	Director	Option Exercise	A	17.15	16,000	274,400	16,000
Apr 24 2019	HOOK	HOOKIPA Pharma Inc ...	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	85,830	0	0
Apr 24 2019	HOOK	HOOKIPA Pharma Inc ...	Redmile Group, LLC	10% Owner	Buy	C	0.00	999,322	0	999,322	0 to 999.3 K
Mar 06 2019	ALDR	ALDER BIOPHARMACEU ...	Redmile Group, LLC	Director	Grant	A	11.50	1,739,130	19,999,995	8,244,896	6.5 M to 8.2 M (+26.73 %)
Feb 21 2019	TCRR	TCR2 THERAPEUTICS ...	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	5,000,000	0	0
Feb 21 2019	TCRR	TCR2 THERAPEUTICS ...	Redmile Group, LLC	10% Owner	Buy	C	0.00	807,256	0	807,256	0 to 807.3 K
Feb 21 2019	XERS	XERIS PHARMACEUTIC ...	Redmile Group, LLC	10% Owner	Buy	P	10.00	588,000	5,880,000	3,000,642	2.4 M to 3 M (+24.37 %)
Jan 03 2019	ALDR	ALDER BIOPHARMACEU ...	Redmile Group, LLC	Director	Option Exercise	J	0.00	18,558	0	760,753
Nov 16 2018	VAPO	VAPOTHERM INC	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	1,759,015	0	0
Nov 16 2018	VAPO	VAPOTHERM INC	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	11,433,597	0	0
Nov 16 2018	VAPO	VAPOTHERM INC	Redmile Group, LLC	10% Owner	Buy	C	0.00	142,857	0	959,540	816.7 K to 959.5 K (+17.49 %)
Nov 16 2018	VAPO	VAPOTHERM INC	Redmile Group, LLC	10% Owner	Buy	C	0.00	816,683	0	816,683	0 to 816.7 K
Oct 03 2018	GRTS	Gritstone Oncology ...	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	153,360	0	0
Oct 03 2018	GRTS	Gritstone Oncology ...	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	371,607	0	0
Oct 03 2018	GRTS	Gritstone Oncology ...	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	869,562	0	0
Oct 03 2018	GRTS	Gritstone Oncology ...	Redmile Group, LLC	10% Owner	Buy	C	0.00	153,360	0	1,394,529	1.2 M to 1.4 M (+12.36 %)
Oct 03 2018	GRTS	Gritstone Oncology ...	Redmile Group, LLC	10% Owner	Buy	C	0.00	371,607	0	1,241,169	869.6 K to 1.2 M (+42.73 %)
Oct 03 2018	GRTS	Gritstone Oncology ...	Redmile Group, LLC	10% Owner	Buy	C	0.00	869,562	0	869,562	0 to 869.6 K
Sep 27 2018	FATE	FATE THERAPEUTICS ...	Redmile Group, LLC	Director	Buy	P	13.50	3,703,704	50,000,004	10,359,666	6.7 M to 10.4 M (+55.64 %)
Aug 02 2018	FATE	FATE THERAPEUTICS ...	Redmile Group, LLC	Director	Option Exercise	A	8.93	24,000	214,320	24,000
Jul 25 2018	REPL	Replimune Group, I ...	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	78,382	0	0
Jul 25 2018	REPL	Replimune Group, I ...	Redmile Group, LLC	10% Owner	Buy	C	0.00	779,655	0	779,655	0 to 779.7 K
Jul 24 2018	ALLK	Allakos Inc.	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	1,261,365	0	0
Jul 24 2018	ALLK	Allakos Inc.	Redmile Group, LLC	10% Owner	Buy	C	0.00	1,009,090	0	1,009,090	0 to 1 M
Jul 18 2018	ALDR	ALDER BIOPHARMACEU ...	Redmile Group, LLC	Director	Option Exercise	J	0.00	16,927	0	742,195
Jun 27 2018	XERS	XERIS PHARMACEUTIC ...	Redmile Group, LLC		Option Exercise	C	0.00	3,109,796	0	0
Jun 27 2018	XERS	XERIS PHARMACEUTIC ...	Redmile Group, LLC		Buy	P	15.00	666,668	10,000,020	2,412,642	1.7 M to 2.4 M (+38.18 %)
Jun 27 2018	XERS	XERIS PHARMACEUTIC ...	Redmile Group, LLC		Buy	C	0.00	1,745,974	0	1,745,974	0 to 1.7 M
May 25 2018	ALDR	ALDER BIOPHARMACEU ...	Redmile Group, LLC		Option Exercise	A	15.50	15,000	232,500	15,000
Apr 26 2018	ALDR	ALDER BIOPHARMACEU ...	Redmile Group, LLC	Director	Option Exercise	A	13.20	30,000	396,000	30,000
Sep 30 2016	ARRY	ARRAY BIOPHARMA IN ...	Redmile Group, LLC	10% Owner	Sell	S	6.36	2,492,578	15,852,796	16,658,072	19.2 M to 16.7 M (-13.02 %)
Sep 16 2016	ARRY	ARRAY BIOPHARMA IN ...	Redmile Group, LLC	10% Owner	Buy	P	3.50	28,000	98,000	19,150,650	19.1 M to 19.2 M (+0.15 %)
Sep 16 2016	ARRY	ARRAY BIOPHARMA IN ...	Redmile Group, LLC	10% Owner	Sell	S	3.54	7,300	25,842	19,122,650	19.1 M to 19.1 M (-0.04 %)
Sep 16 2016	ARRY	ARRAY BIOPHARMA IN ...	Redmile Group, LLC	10% Owner	Buy	P	3.51	372,000	1,305,720	19,129,950	18.8 M to 19.1 M (+1.98 %)
Sep 16 2016	ARRY	ARRAY BIOPHARMA IN ...	Redmile Group, LLC	10% Owner	Sell	S	3.50	392,700	1,374,450	18,757,950	19.2 M to 18.8 M (-2.05 %)
Jul 07 2016	SYRS	Syros Pharmaceutic ...	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	151,576	0	0
Jul 07 2016	SYRS	Syros Pharmaceutic ...	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	117,931	0	0
Jul 07 2016	SYRS	Syros Pharmaceutic ...	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	982,762	0	0
Jul 07 2016	SYRS	Syros Pharmaceutic ...	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	178,074	0	0
Jul 07 2016	SYRS	Syros Pharmaceutic ...	Redmile Group, LLC	10% Owner	Option Exercise	C	0.00	317,853	0	0
Jul 07 2016	SYRS	Syros Pharmaceutic ...	Redmile Group, LLC	10% Owner	Buy	P	12.50	9,373	117,163	49,793	40.4 K to 49.8 K (+23.19 %)
Jul 07 2016	SYRS	Syros Pharmaceutic ...	Redmile Group, LLC	10% Owner	Buy	P	12.50	174,320	2,179,000	205,767	31.4 K to 205.8 K (+554.33 %)
Jul 07 2016	SYRS	Syros Pharmaceutic ...	Redmile Group, LLC	10% Owner	Buy	P	12.50	104,670	1,308,375	366,739	262.1 K to 366.7 K (+39.94 %)
Jul 07 2016	SYRS	Syros Pharmaceutic ...	Redmile Group, LLC	10% Owner	Buy	P	12.50	144,383	1,804,788	191,869	47.5 K to 191.9 K (+304.05 %)
Jul 07 2016	SYRS	Syros Pharmaceutic ...	Redmile Group, LLC	10% Owner	Buy	C	0.00	40,420	0	40,420	0 to 40.4 K
Jul 07 2016	SYRS	Syros Pharmaceutic ...	Redmile Group, LLC	10% Owner	Buy	C	0.00	31,447	0	31,447	0 to 31.4 K
Jul 07 2016	SYRS	Syros Pharmaceutic ...	Redmile Group, LLC	10% Owner	Buy	C	0.00	262,069	0	262,069	0 to 262.1 K
Jul 07 2016	SYRS	Syros Pharmaceutic ...	Redmile Group, LLC	10% Owner	Buy	C	0.00	47,486	0	47,486	0 to 47.5 K
Jul 07 2016	SYRS	Syros Pharmaceutic ...	Redmile Group, LLC	10% Owner	Buy	C	0.00	84,760	0	84,760	0 to 84.8 K
Jun 13 2016	FOLD	AMICUS THERAPEUTIC ...	Redmile Group, LLC	10% Owner	Buy	P	7.20	66,300	477,360	12,956,446	12.9 M to 13 M (+0.51 %)
Jan 22 2016	ARRY	ARRAY BIOPHARMA IN ...	Redmile Group, LLC	10% Owner	Buy	P	3.19	300,000	957,000	19,150,650	18.9 M to 19.2 M (+1.59 %)
Jan 14 2016	ARRY	ARRAY BIOPHARMA IN ...	Redmile Group, LLC	10% Owner	Buy	P	3.60	75,000	270,000	18,850,650	18.8 M to 18.9 M (+0.40 %)
Jan 11 2016	ARRY	ARRAY BIOPHARMA IN ...	Redmile Group, LLC	10% Owner	Buy	P	3.54	275,000	973,500	18,775,650	18.5 M to 18.8 M (+1.49 %)
Jan 11 2016	ARRY	ARRAY BIOPHARMA IN ...	Redmile Group, LLC	10% Owner	Buy	P	3.72	350,000	1,302,000	18,500,650	18.2 M to 18.5 M (+1.93 %)
Jan 11 2016	ARRY	ARRAY BIOPHARMA IN ...	Redmile Group, LLC	10% Owner	Buy	P	3.73	300,000	1,119,000	18,150,650	17.9 M to 18.2 M (+1.68 %)
Oct 01 2015	ARRY	ARRAY BIOPHARMA IN ...	Redmile Group, LLC	10% Owner	Buy	P	4.50	100,140	450,630	18,033,102	17.9 M to 18 M (+0.56 %)
Oct 01 2015	ARRY	ARRAY BIOPHARMA IN ...	Redmile Group, LLC	10% Owner	Buy	P	4.67	182,452	852,051	17,932,962	17.8 M to 17.9 M (+1.03 %)
Oct 01 2015	ARRY	ARRAY BIOPHARMA IN ...	Redmile Group, LLC	10% Owner	Buy	P	4.56	500,000	2,280,000	17,750,510	17.3 M to 17.8 M (+2.90 %)
Aug 28 2015	ARRY	ARRAY BIOPHARMA IN ...	Redmile Group, LLC	10% Owner	Buy	P	5.48	49,900	273,452	17,250,510	17.2 M to 17.3 M (+0.29 %)

Page: 1 2 next >